Last 779.45 INR
Change Today +9.20 / 1.19%
Volume 541.1K
As of 6:05 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rajesh V. Desai

Chief Financial Officer and Executive Director, Glenmark Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 2 different industries.

See Board Relationships
5633,371,666
As of Fiscal Year 2014

Background*

Mr. Rajesh V. Desai serves as the Chief Financial Officer of Glenmark Pharmaceuticals Ltd. Mr. Desai has over 26 years experience in the pharmaceutical industry. He joined GPL in 1983 and previously employed with Progressive Business Consultants Private Limited. He served as Director for IT, Legal & Finance of Glenmark Pharmaceuticals Ltd. Mr. Desai has been the Non-Executive Director at Glenmark Generics Ltd. since August 14, 2009. Mr. Desai has been an Executive Director ...

Read Full Background

Corporate Headquarters*

Glenmark House
Mumbai, Maharashtra 400099

India

Phone: 91 22 4018 9999
Fax: 91 22 4018 9990

Board Members Memberships*

Non-Executive Director and Member of Shareholders/Investors Grievances Committee
2011-Present
Chief Financial Officer and Executive Director

Education*

Unknown/Other Education
University of Mumbai
Unknown/Other Education
Institute of Chartered Accountants of India

Other Affiliations*

Annual Compensation*

Salary16,259,169
Total Annual Compensation16,259,169

Stock Options*

All Other Compensation17,112,497

Total Compensation*

Total Annual Cash Compensation33,371,666
Total Short Term Compensation16,259,169
Other Long Term Compensation17,112,497
Total Calculated Compensation33,371,666
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNP:IN 779.45 INR +9.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Pankaj R. Patel M.PharmChairman, Managing Director, Chairman of Share Transfer Committee, Chairman of Committee of Directors and Member of Shareholders'/Investors' Grievance Committee
Cadila Healthcare Limited
--
Arun Sawhney B.Com., P.G.D.B.M.Chief Executive Officer, Managing Director, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Quality & Integrity Committee, Member of Science Committee and Member of Corporate Social Responsibility Committee
Ranbaxy Laboratories Ltd.
122.7M
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Vivek Dhawan Chief Executive Officer, Chief Coach, Director and Member of Remuneration & Nomination Committee
Mega Lifesciences Public Company Limited
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLENMARK PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.